HANDS-ON LEARNING FOR THE ENTIRE FAMILY
Science fairs are a cornerstone of science education. Believe Limited brings both the fundamental and breakthrough science of the day in hemophilia and bleeding disorders to BDC, turning it all into a larger-than-life, community-facing Science Fair comprised of various modules with both visual and tactile experiences.
INSPIRING YOUNG COMMUNITY MEMBERS
The inaugural Science Fair presented teens, adults, and families alike the opportunity to learn about the science behind bleeding disorders by combining the interactivity of a true "science center" exhibit with the visual style of the classic science fairs we all grew up with: oversized, brightly-colored trifolds with hosted, interactive exhibits that young people and families can approach and engage with instantly.
OUR YEAR-ROUND COMMITMENT
The annual Science Fair takes place at National Hemophilia Foundation’s Bleeding Disorders Conference, but our commitment to bringing scientific education and engagement to the community is just getting started. Starting in 2023, a "road show" version of The Science Fair™ will be made available to select patient advocacy organizations throughout the United States.
Want to have The Science Fair at your local patient meeting? Contact us and let us know!
BUILT WITH GUIDANCE FROM LEADING CLINICIANS & EXPERTS
Leading Clinicians from around the country have donated their time to help Believe Limited translate some of the most important scientific concepts in our community into tactile learning opportunities for young people and families. With their guidance we’ve created the first-of-its-kind, hands-on community Science Fair, bringing education and engagement to NHF BDC annually. Meet our Scientific Advisors below.
DR. MICHAEL WANG, MD
Dr. Michael Wang is a pediatric hematologist-oncologist in Aurora, Colorado and is affiliated with multiple hospitals in the area, including Children's Hospital Colorado and UCHealth University of Colorado Hospital. He is the Clinical Director for the Hemophilia Treatment Center in Denver, CO. He received his medical degree from the University of Rochester School of Medicine and Dentistry and has been in practice for more than 20 years.
(Full Bio)
DR. DORIS QUON, MD
Doris V. Quon, MD, PhD is board-certified in Hematology and Internal Medicine She obtained her Ph.D. in Microbiology & Immunotherapy as well as her M.D. at the UCLA School of Medicine, and did her Residency in Internal Medicine and Fellowship in Hematology-Oncology at Medical Center at UCLA. Dr. Quon first began at the Hemophilia Treatment Center at Orthopaedic Hospital in 2003 where, within a few years, she was appointed Associate Director, followed by the position of Director of the Hemophilia Treatment Center in 2009.
(Full Bio)
BRENDAN HAYES
Brendan Hayes is the Director of External Affairs at the National Hemophilia Foundation and leads NHF’s Gene Therapy Initiative which includes developing accurate, non-biased educational content on gene therapy, working with payers and policymakers to ensure patients have access to these groundbreaking therapies, and strengthening collaborations with national rare disease and patient advocacy organizations.
(Full Bio)
DR. STEVEN PIPE, MD
Dr. Steven Pipe completed his undergraduate medical training at the University of Toronto, and his pediatric training at McMaster University in Hamilton, Ontario. He came to the University of Michigan in 1993 and completed his pediatric hematology and oncology training in 1996. Dr. Pipe is an Associate Professor of Pediatrics and Pathology and currently serves as Director of the Division of Pediatric Hematology and Oncology, Pediatric Medical Director of the Hemophilia and Coagulation Disorders Program and Director of the Special Coagulation Laboratory.
(Full Bio)
DR. GLENN PIERCE, MD
Dr. Glenn Pierce is currently an independent consultant, entrepreneur-in-residence at Third Rock Ventures and serves on the World Federation of Hemophilia (WFH) and WFHUSA Board of Directors and the National Hemophilia Foundation (NHF) (US) Medical and Scientific Advisory Council. Glenn is also a director of Voyager Therapeutics and Global Blood Therapeutics, two publicly held biotechnology companies.
(Full Bio)
DR. CHRISTOPHER WALSH, MD, PhD
Christopher E. Walsh, MD, PhD, is Associate Professor and Director of the Hemophilia Program in the Division of Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai in New York City. He received his PhD in Biochemistry from Wake Forest School of Medicine and his MD from Tulane University School of Medicine.
(Full Bio)
DR. CINDY BAILEY, PT, PhD
Cindy Bailey is a past Assistant Professor of Clinical Practice in the Dept. of Biokinesiology & Physical Therapy at the University of Southern California (USC) & is currently Clinical Faculty at Mount Saint Mary's Physical Therapy Doctorate program. She is the Director of P.T./O.T. at Los Angeles Orthopaedic Institute for Children (OIC) and the Physical Therapist for the Orthopaedic Hemophilia Treatment Center.
(Full Bio)
DR. MICHAEL TARANTINO, MD
Dr. Tarantino has 25 years of experience in hematology, with seven years as the Founder, Medical Director and President of the Bleeding & Clotting Disorders Institute. For over two decades he has devoted his medical career to the management of bleeding and clotting disorders, as well as non-malignant hematology disorders. Dr. Tarantino also serves as the medical director of the Anticoagulation Consultation Service at St. Francis Medical Center and co-chairs the Anti-thrombosis subcommittee.